Related Experiment Videos
Pathogenesis and pathophysiology of bacterial meningitis
1Department of Internal Medicine (Infectious Diseases), Medical College of Pennsylvania, Philadelphia 19129.
Clinical Microbiology Reviews
|April 1, 1993
Summary
Bacterial meningitis causes significant illness and death, even with antibiotics. Understanding its pathogenesis and pathophysiology is key to developing new treatments and prevention strategies.
Area of Science:
- Infectious Diseases
- Neuroscience
- Immunology
Background:
- Bacterial meningitis presents significant morbidity and mortality despite effective antimicrobial treatments.
- Experimental animal models have elucidated key pathogenic and pathophysiologic mechanisms.
- Disease progression involves nasopharyngeal colonization, bacteremia, and central nervous system invasion.
Purpose of the Study:
- To review the pathogenesis and pathophysiology of bacterial meningitis.
- To highlight the role of bacterial factors and host inflammatory responses.
- To discuss potential therapeutic strategies, including adjunctive dexamethasone therapy.
Main Methods:
- Review of experimental animal models of bacterial meningitis.
- Analysis of bacterial virulence factors and host inflammatory mediators.
- Examination of the blood-brain barrier's role in central nervous system invasion.
- Evaluation of adjunctive dexamethasone therapy's effects on inflammatory markers.
Main Results:
- Bacterial encapsulation promotes bacteremia by evading phagocytosis and complement.
- Pathogens increase blood-brain barrier permeability via virulence factors and cytokine induction.
- Intense subarachnoid inflammation leads to cerebral edema and increased intracranial pressure.
- Dexamethasone therapy may reduce inflammatory markers like tumor necrosis factor and cerebrospinal fluid leukocytosis.
Conclusions:
- Further research into bacterial meningitis pathogenesis and pathophysiology is crucial.
- Understanding these mechanisms can guide the development of novel treatments and preventive measures.
- Adjunctive therapies like dexamethasone show promise in mitigating inflammatory consequences.